Simple Blood Test Could Predict Preemie Lung Disease
A groundbreaking new study reveals a simple blood test may soon predict which preterm babies face the risk of chronic lung disease. This breakthrough promises earlier diagnosis and targeted treatment for vulnerable infants.
Key Protein Markers Give Early Warning
Researchers at the Murdoch Children’s Research Institute (MCRI) have identified specific changes in blood proteins that, combined with factors like gestational age, birth weight, and sex, can predict bronchopulmonary dysplasia (BPD) within just 72 hours of birth.
BPD is a severe condition affecting around 65% of preemies, caused by lung damage from respiratory support and prolonged oxygen use. It can result in lifelong lung problems and neurodevelopmental disabilities.
Changing the Game in Neonatal Care
Currently, BPD is diagnosed weeks or months after birth—often when serious lung damage has already set in. This new blood test could revolutionise care by identifying high-risk infants far earlier.
“Our study shows that a simple blood test could be a game-changer in predicting which infants will develop BPD, enabling us to intervene earlier and potentially reduce the severity of the disease,” said the lead researcher at MCRI.
Boosting Survival Chances for Preemies
The test analyses blood samples for protein markers linked to BPD risk, creating a predictive model that could be used globally in neonatal intensive care units. With more validation, this could become a standard part of newborn care.
Experts say this breakthrough is a major leap forward in neonatal medicine, offering hope to thousands of fragile babies and their families.
